2009
DOI: 10.1016/j.biortech.2009.06.006
|View full text |Cite
|
Sign up to set email alerts
|

Highly enantioselective reduction of 4-(trimethylsilyl)-3-butyn-2-one to enantiopure (R)-4-(trimethylsilyl)-3-butyn-2-ol using a novel strain Acetobacter sp. CCTCC M209061

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
20
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 20 publications
(20 citation statements)
references
References 24 publications
0
20
0
Order By: Relevance
“…CCTCC M209061, it was possible that the change in culture conditions might affect the rate of reduction of different substrates to different extents. The cells cultured in the improved medium were therefore tested as the biocatalyst for the key enantioselective reduction of 4-(trimethylsilyl)-3-butyn-2-one to ( R ) - 4-(trimethylsilyl)-3-butyn-2-ol that we investigated previously [10]. Compared with the previous work, using cells prepared from the optimized reaction medium, under the reduction reaction conditions described previously, the initial reaction rate increased from 0.5 μ mol/min to 1.13 μ mol/min; the yield was enhanced from 71% to 83% and the product e.e .…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…CCTCC M209061, it was possible that the change in culture conditions might affect the rate of reduction of different substrates to different extents. The cells cultured in the improved medium were therefore tested as the biocatalyst for the key enantioselective reduction of 4-(trimethylsilyl)-3-butyn-2-one to ( R ) - 4-(trimethylsilyl)-3-butyn-2-ol that we investigated previously [10]. Compared with the previous work, using cells prepared from the optimized reaction medium, under the reduction reaction conditions described previously, the initial reaction rate increased from 0.5 μ mol/min to 1.13 μ mol/min; the yield was enhanced from 71% to 83% and the product e.e .…”
Section: Resultsmentioning
confidence: 99%
“…A novel strain, Acetobacter sp. CCTCC M209061, reported in our previous paper [10], isolated from Chinese kefir grains, showed exclusive anti-Prelog stereoselectivity for the reduction of 4-(trimethylsilyl)-3-butyn-2-one to ( R )-4-(trimethylsilyl)-3-butyn-2-ol, which is a key chiral intermediate for the synthesis of ( R )-benzyl-4-hydroxyl-2-pentynoate, a molecule that has potential therapeutic function for Alzheimer's disease. Also, Acetobacter sp.…”
Section: Introductionmentioning
confidence: 99%
“…A variety of microorganisms have been reported to be efficient in catalyzing prochrial ketones to enantiomerically pure chrial alcohols [16,25-29]. Therefore, several commercial available microorganisms ( Acetobacter pasteurianus GIM1.158, Acetobacter sp.…”
Section: Resultsmentioning
confidence: 99%
“…However, to our best knowledge, the use of Acetobacter sp . as a biocatalyst for the asymmetric reduction of prochiral ketones remains unexplored, with only few accounts published by us [16,20,23,24]. In these cases, a new acetic acid bacterium, Acetobacter sp.…”
Section: Introductionmentioning
confidence: 99%
“…ILs with an appropriate concentration can support a highly efficient whole-cell biocatalytic process. However, when concentrations of ILs in the reaction system are too high, they can retard the enzymatic activity and limit the mass transfer of substrate [26,27]. Therefore, the influence of [BPy]BF 4 concentration on the GDL biosynthesis of Y. lipolytica G3-3.21 was tested in this study.…”
Section: Optimization Of [Bpy]bf 4 Concentrationmentioning
confidence: 99%